Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Supplemental testosterone may lower liver cancer risk in hepatitis C patients.

Keratin 19 may help diagnose and treat certain types of permanent hair loss.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

PCFCL may have unrecognized subtypes and needs more research.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

The assay effectively identifies compounds that affect immune cell activation.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Keratin 19 forms less stable and shorter filaments than keratin 14, giving unique traits to certain skin cells.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

CMV infection increases the risk of GvHD after bone marrow transplants.

Enhancing Tregs can protect against alopecia areata.

lncRNA2919 slows down rabbit hair growth by stopping cell growth and causing cell death.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.